4/A//SEC Filing
Kaufmann Gunnar F. 4/A
Accession 0001209191-20-044385
CIK 0001260990other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 9:06 PM ET
Size
5.8 KB
Accession
0001209191-20-044385
Insider Transaction Report
Form 4/AAmended
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Award
Stock Option
2020-03-17+14,260→ 14,260 totalExercise: $3.33Exp: 2030-03-17→ Common Stock (14,260 underlying)
Footnotes (2)
- [F1]The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
- [F2]Fully vested on grant date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001786754
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 9:06 PM ET
- Size
- 5.8 KB